Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05862961

Better Classification of Respiratory Amyloidosis

Towards a Better Classification of Respiratory Amyloidosis. Contribution of Proteomic Analysis Based on Tandem Mass Spectrometry

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The B-AR project is based on a retrospective analysis of amyloidosis typing and the identification of their amylogenic protein.This work should be able to unite many clinicians, including pulmonologists and pathologists around a rare disease that still suffers from insufficient data.

Detailed description

The B-AR study will highlight the interest of proteomic analysis of amyloidosis compared to their identification by immunostaining. The objective is to reduce diagnostic wandering and to improve patient management. The typing of respiratory amyloidosis will allow a better characterization of the disease and thus, to propose a dedicated therapeutic management.

Conditions

Timeline

Start date
2023-05-15
Primary completion
2025-05-15
Completion
2026-05-15
First posted
2023-05-17
Last updated
2023-05-17

Source: ClinicalTrials.gov record NCT05862961. Inclusion in this directory is not an endorsement.

Better Classification of Respiratory Amyloidosis (NCT05862961) · Clinical Trials Directory